Avacta Group Plc Stock Rating Reaffirmed by Panmure Gordon (AVCT)
Avacta Group Plc (LON:AVCT)‘s stock had its “buy” rating reiterated by equities research analysts at Panmure Gordon in a research note issued to investors on Monday. They currently have a GBX 1.75 ($0.03) price objective on the stock. Panmure Gordon’s target price points to a potential upside of 94.66% from the stock’s previous close.
A number of other analysts have also recently weighed in on AVCT. Analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Avacta Group Plc in a research note on Friday.
Avacta Group Plc (LON:AVCT) opened at 0.89 on Monday. Avacta Group Plc has a one year low of GBX 1.02 and a one year high of GBX 1.204. The stock has a 50-day moving average of GBX 1.11 and a 200-day moving average of GBX 1.14.
Avacta Group plc is engaged in healthcare equipment and instrumentation business, provides technologies and services to the life sciences/healthcare sector through two operating divisions: Avacta Analytical and Avacta Animal Health.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.